Get GTN Insights by Email
Copay + GTN Revenue Protection = Better Together
Gerard Rivera
Gerard Rivera Co-founder & CEO
2027 Is Already Here: An Interview With Dan Bench, PharmD
Chase Carpenter
Chase Carpenter VP, Growth
Daniel Lozano on eBV 2.0: Moving Beyond the Checkbox
Chase Carpenter
Chase Carpenter VP, Growth
The New Maximizer Playbook: What’s Changed–And What to Do About It
Gerard Rivera
Gerard Rivera Co-founder & CEO
Stephen Hom
Stephen Hom Co-founder & COO
What You and Your Team Need to Know About Pharmacy Copay Misuse
Gerard Rivera
Gerard Rivera Co-founder & CEO
The RIS Rx Pharmacy Fellowship Returns for 2027–2028
Lia Basilio
Lia Basilio Talent Acquisition Manager & People Ops Business Partner
RIS Rx Extends Triple A Platform with Real-Time Monitoring Backed by PharmD-to-PharmD Engagement
Chase Carpenter
Chase Carpenter VP, Growth
Inside the RIS Rx Security and Data Privacy Program: 5 Safeguards Every Manufacturer Should Verify
Matthew Webster
Matthew Webster Chief Information Security Officer
Careen Martin
Careen Martin Chief Compliance & Privacy Officer
Diann Dalton Potestio On The Hidden Cost of Waiting
Chase Carpenter
Chase Carpenter VP, Growth

Learn why the world‘s top pharmaceutical companies trust RIS Rx to protect their patients and improve GTN.